Clinical Project Manager

Summary

The Clinical Project Manager plays a crucial role in facilitating the delivery of the sponsor's assets into the clinic. This position requires a blend of adeptness in clinical project management, site monitoring, and external stakeholder management. The ideal candidate must be flexible, possess a willingness to problem‑solve under time constraints, and express an enthusiasm for learning new tasks outside the traditional clinical PM / CRA role. The role will collaborate closely with the Australian Clinical Operations manager, cross‑functional teams, vendors, and investigative sites to support the efficient conduct of clinical trials.

Main Duties and Responsibilities

• Execute on the clinical development strategy in Australia.
• Work in partnership with the local CRO and the ARTBIO in‑house clinical operations, quality, technical operations, and regulatory team to provide oversight, training, and management of Australian clinical sites performing ARTBIO‑sponsored clinical studies.
• Work as the local representative for submissions to regulators and for the identification of clinical sites.
• Work in partnership with the management team to build out the local network of KOLs, radiopharmacy, and theranostic centers who can recruit, administer RLTs, and conduct studies in Australia.
• Work with the business development and management team to keep abreast of the local environment and competitive landscape.
• Will serve as the second employee for the newly established legal entity in Australia (early 2025).
• Flexibility with working hours to accommodate meetings and timelines when needed due to global business needs.

Clinical Project Management and Monitoring

Qualifications

Knowledge, Skills & Abilities Required

About Us

ARTBIO is redefining cancer care by developing a new class of radioligand therapies (RLT) which harness the power of 212Pb and deliver it directly to the tumor. Targeted RLT is one of the fastest growing areas of oncology research and investment. The foundational technology, termed AlphaDirect™, was born out of elegant research by our scientific founders, Roy Larsen and Øyvind Bruland, inventors of XofigoTM. ARTBIO is leveraging this groundbreaking science and expediting novel Drug Discovery targets which broadly exploit the unmet medical need and opportunity in revolutionising cancer care. Supported by a committed investment board including Omega Funds, F‑Prime Capital, Radforsk and Third Rock Ventures, ARTBIO has built a highly experienced, multi‑disciplinary team of drug‑hunters and developers. For more information on our strategy and emerging pipeline, please visit www.artbio.com and follow us on LinkedIn.

As an emerging, global biotech with locations in Cambridge, Basel, London, and Oslo, we take advantage of diverse scientific depth and insights which makes ARTBIO a unique place to work. We are driven by a desire to do better for cancer patients, lowering the burden of toleration and safety while at the same time raising the bar on clinical efficacy and duration.

EEO Statement

ARTBIO is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status. If you have a disability or special need that requires accommodation, please let us know.

Questions and Application Process

If interested, please apply and send your CV to HR@artbio.com; All inquiries are treated confidentially.

ARTBIO does not accept unsolicited resumes from external agencies or recruiters. Submission of a resume without a prior written agreement does not create any express or implied contract between ARTBIO and the agency. ARTBIO will not pay any fees related to unsolicited resumes.

#J-18808-Ljbffr